ALM-22703-47806
4 vaccinations
13 coded responses
48 check-ins
13 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 891 / NV
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-19
Registered in v-safe
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-19
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-27
- 2021-01-01
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-23
-
2021-01-28
Survey response — day 21, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Dizziness occasionallyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-12
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-10-15
Dose 3 — Pfizer-BioNTech
-
2021-10-17
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Lymph node pain and swelling in axilla and clavicleMedDRA releases: 2024-11 · check-in free text available
-
2021-10-18
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes: axillary and clavicle lymph nodes, more swollen than yesterdayMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen lymph nodes: axillary and clavicleMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Swollen and painful lymph nodes axillary and clavicle,MedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — days 1–6 daily, dose 3MedDRA: Discomfort, Oedema peripheral, Swelling — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swelling in axillary and clavicle remains present and uncomfortableMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Survey response — day 7, dose 3MedDRA: Axillary pain, Dizziness, Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Dizziness, swollen lymph nodes axillary and clavicle, pain in armpitMedDRA releases: 2024-11 · check-in free text available
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-28
-
2022-01-14
Survey response — 3 months, dose 3MedDRA: Headache, Throat irritation — Feeling: GoodFree text: Scratchy throat, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-04-15
-
2022-11-13
Dose 4 — Pfizer-BioNTech
-
2022-11-13
Health check-in — day 0, dose 4Feeling: Good · Site: Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-11-14
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph node swelling in armpitsMedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Fair · Fatigue or tirednessFree text: Pain at swollen lymph node in armpitMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Survey response — days 1–6 daily, dose 4MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: Lymph node swelling, painful underarmMedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2022-11-20
- 2022-11-27
- 2022-12-04
- 2022-12-11
-
2022-12-18
Survey response — day 35, dose 4MedDRA: Fatigue, Headache, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, body aches, fatigue, headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-12-25
- 2023-02-12
- 2023-05-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-10-15 | Pfizer-BioNTech | No |
| 4 | 2022-11-13 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 2 — day 21, dose 2
Symptoms: Dizziness occasionally
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph node pain and swelling in axilla and clavicle
Systemic reaction (other): Swollen lymph nodes: axillary and clavicle lymph nodes, more swollen than yesterday
Systemic reaction (other): Swollen lymph nodes: axillary and clavicle
Systemic reaction (other): Swollen and painful lymph nodes axillary and clavicle,
Systemic reaction (other): Swelling in axillary and clavicle remains present and uncomfortable
Release 10 — day 7, dose 3
Systemic reaction (other): Dizziness, swollen lymph nodes axillary and clavicle, pain in armpit
Release 10 — 3 months, dose 3
Symptoms: Scratchy throat, headache
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Lymph node swelling in armpits
Systemic reaction (other): Pain at swollen lymph node in armpit
Systemic reaction (other): Lymph node swelling, painful underarm
Release 12 — day 35, dose 4
Symptoms: Fever, body aches, fatigue, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Discomfort | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release